Synopsys (SNPS) awards 4,317 restricted stock units to CAO Kankanwadi

Rhea-AI Filing Summary

Synopsys, Inc. reported an equity award for its Chief Accounting Officer, Sudhindra Kankanwadi. On 12/16/2025, he received a grant of 4,317 restricted stock units (RSUs) under the Synopsys, Inc. 2006 Employee Equity Incentive Plan. Each RSU represents a right to receive one share of Synopsys common stock for no cash exercise price.

According to the vesting schedule, one-sixth of the units vest on 06/15/2026, with the remaining units vesting in five equal semi-annual installments through 12/15/2028, as long as he continues to provide service to the company through each vesting date. This filing reflects a routine compensation-related grant rather than a market sale or purchase of shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kankanwadi Sudhindra

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.0	12/16/2025		A(1)		4,317		06/15/2026(2)	12/15/2028	Common Stock	4,317	$0.0	4,317	D

Explanation of Responses:

1. The Compensation Committee of the Board of Directors approved a restricted stock unit grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

2. One-sixth (1/6) of the units vest on the date shown followed by five equal semi-annual installments, subject to continued service through each vesting date.

	By: POA pursuant Mary Lai For: Sudhindra Kankanwadi	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity transaction did Synopsys (SNPS) disclose for 12/16/2025?

Synopsys disclosed that its Chief Accounting Officer, Sudhindra Kankanwadi, received a grant of 4,317 restricted stock units on 12/16/2025 under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.

Who is the reporting person in this Synopsys (SNPS) Form 4 filing?

The reporting person is Sudhindra Kankanwadi, who serves as Chief Accounting Officer of Synopsys, Inc., as indicated in the relationship section of the filing.

How many Synopsys (SNPS) restricted stock units were granted in this transaction?

The filing reports a grant of 4,317 restricted stock units, each linked to a share of Synopsys common stock with an exercise price of $0.0.

What is the vesting schedule for the 4,317 RSUs granted by Synopsys (SNPS)?

The filing states that one-sixth (1/6) of the units vest on 06/15/2026, and the remaining units vest in five equal semi-annual installments through 12/15/2028, subject to continued service through each vesting date.

Under which plan were the Synopsys (SNPS) RSUs granted to the Chief Accounting Officer?

The RSUs were approved by the Compensation Committee as a grant under the Synopsys, Inc. 2006 Employee Equity Incentive Plan, as explained in the responses section.

Does this Synopsys (SNPS) Form 4 reflect a purchase or sale of common stock?

The document describes a grant of restricted stock units with an exercise price of $0.0 rather than an open market purchase or sale of Synopsys common stock.